(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 20.83% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.2%.
Delcath Systems's revenue in 2026 is $90,441,000.On average, 8 Wall Street analysts forecast DCTH's revenue for 2026 to be $3,635,474,646, with the lowest DCTH revenue forecast at $3,444,017,591, and the highest DCTH revenue forecast at $3,802,559,417. On average, 8 Wall Street analysts forecast DCTH's revenue for 2027 to be $4,599,664,246, with the lowest DCTH revenue forecast at $4,097,029,066, and the highest DCTH revenue forecast at $4,951,439,829.
In 2028, DCTH is forecast to generate $5,496,191,419 in revenue, with the lowest revenue forecast at $4,641,780,656 and the highest revenue forecast at $6,153,138,361.